Firebrick Pharma Limited
FRE
Rank in Stocks
#30493
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Share Price
$0.01923025
Last synced: 2026-11-09
Market Cap
$5.05M
Change (1 day)
-0.78%
Change (1 year)
-53.31%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Firebrick Pharma Limited (FRE)
Category
Healthcare
Operating Margin for Firebrick Pharma Limited (FRE)
Operating Margin as of November 2026 TTM: -2,925.61%
According to Firebrick Pharma Limited's latest financial reports, its current operating margin (TTM) is -2,925.61%. At the end of 2025 the company had an operating margin of -976.65%.
Operating Margin history for Firebrick Pharma Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2,925.61% | 199.56% |
| 2025 | -976.65% | -96.39% |
| 2024 | -27,045.99% | -96.73% |
| 2023 | -826,956.63% | 915.78% |
| 2022 | -81,410.81% | 11,904.84% |
| 2021 | -678.15% | 71.90% |
| 2020 | -394.51% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 46.07% | -100.02% |
US
|
|
| 25.70% | -100.01% |
US
|
|
| 35.53% | -100.01% |
US
|
|
| 16.24% | -100.01% |
US
|
|
| 31.92% | -100.01% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Firebrick Pharma Limited's operating margin
What is Firebrick Pharma Limited's operating margin?
Firebrick Pharma Limited's operating margin is -2,925.61%, as of Nov 2026.
What was Firebrick Pharma Limited's operating margin in 2025?
In 2025, Firebrick Pharma Limited's operating margin was -976.65%, compared with -27,045.99% in 2024.
How has Firebrick Pharma Limited's operating margin changed since 2020?
From 2020 to 2025, Firebrick Pharma Limited's operating margin was highest in 2020 (-394.51%) and lowest in 2023 (-826,956.63%).
How does Firebrick Pharma Limited's operating margin compare with similar companies?
Firebrick Pharma Limited's operating margin (-2,925.61%) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with 46.07%.